Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Biocure Technology Inc C.CURE

Alternate Symbol(s):  BICTF

Biocure Technology Inc is a South Korean based Bio Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is in the process of preclinical trials of five major biosimilar products in South Korea, including Interferon Beta 1b, PEGFilgrastim and Ranibizumab as well as CAR-T Cell Therapy. Interferon Beta 1b is used for treating relapsing forms of multiple sclerosis Filgrastim is used to treat neutropenia, a lack of certain white blood cells caused by bone marrow transplants, chemotherapy, and other conditions. Ranibizumab is used for treating macular degeneration. It is also used to treat a type of eye problem known as macular edema, as well as certain eye problems caused by diabetes.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:CURE)

Fundamentals Snapshot (CSE:CURE)

Opinion & Analysis (CSE:CURE)

No current opinion is available.

Bullboard Posts (CSE:CURE)

update and Intent to Apply for Patents

Vancouver, British Columbia--(Newsfile Corp. - August 30, 2021) - BioCure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (FSE: 1WH) ("...
Betteryear2 - August 30, 2021

Great News but nobody is buying.

Sounds very promising to treat cancer. Is there anyone who can shed more light on this discovery. This could be huge but why nobody is...
sailor1986 - October 16, 2018

Great News under radar

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aCURE-2670717&symbol=CURE&region=C The trial results demonstrated a complete...
rocman01 - October 16, 2018

New Bio-Pharmaceutical Company on the CSE

RTO of Gravis Energy is now a new Korean Bio-Pharmaceutical Company on the CSE. Do your own DD.
GMon - December 7, 2017